European Urology
- ISSN:
- 0302-2838
1
h-index
1
Citations
2
Works
Trust signals
1 of 3 signals presentIndependent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.
- DOAJNo datadoaj.org
- OAK listNo dataOAK
- Valid ISSNPresentISSN
This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.
Trends over time
Performance over time
Citation overview
Publications (bars) and citations (line) by year
- Publications
- Citations
Citation history
Publication history
h-index evolution
Cumulative h-index by year
Most-cited works
- Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia20081 citations
- Reply to Tomasz Drewa and Piotr Chlosta's Letter to the Editor re: Frans Debruyne, Arkadij A. Gres, Dmitrii L. Arustamov. Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia. Eur Urol 2008;54:170–8020080 citations